Madden Advisory Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-546
Closed -$32K 196
2017
Q1
$32K Buy
+546
New +$31.9K 0.02% 140
2015
Q4
Sell
-658
Closed -$43K 224
2015
Q3
$43K Buy
658
+508
+339% +$39.5K 0.03% 132
2015
Q2
$11K Buy
+150
New +$11.7K 0.01% 217
2015
Q1
Sell
-150
Closed -$10K 218
2014
Q4
$10K Hold
150
0.01% 233
2014
Q3
$10K Hold
150
0.01% 292
2014
Q2
$9K Hold
150
﹤0.01% 285
2014
Q1
$8K Hold
150
﹤0.01% 280
2013
Q4
$8K Hold
150
0.01% 244
2013
Q3
$7K Sell
150
-150
-50% -$6.84K 0.01% 222
2013
Q2
$13K Buy
+300
New +$12.5K 0.01% 203

Other funds holding PJP

Madden Advisory Services's PJP Position: Q2 2017 in Review

Madden Advisory Services sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2017, closing a stake of 546 shares — an estimated $32K sold.

Madden Advisory Services first reported a position in PJP in Q2 2013 and held it in 10 quarters. The position peaked at $43K in Q3 2015. 99 funds tracked by Wall St. Rank hold PJP as of Q2 2017.

  • Madden Advisory Services reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2017 after selling out during the quarter.
  • Madden Advisory Services sold 546 Invesco Pharmaceuticals ETF shares in Q2 2017, an estimated $32K.
  • Madden Advisory Services first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 10 quarters.
  • Madden Advisory Services's Invesco Pharmaceuticals ETF position peaked at $43K in Q3 2015.
  • 99 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2017.

Based on Madden Advisory Services's 13F filing for Q2 2017, filed 11 Aug 2017.